Trobalt tablets starter pack Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

trobalt tablets starter pack

glaxosmithkline uk ltd - not applicable

TROBALT 50 MG Iisrael - inglise - Ministry of Health

trobalt 50 mg

glaxo smith kline (israel) ltd - retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

TROBALT 50 MG,TROBALT 100 MG Iisrael - inglise - Ministry of Health

trobalt 50 mg,trobalt 100 mg

glaxo smith kline (israel) ltd - retigabine 100 mg; retigabine 50 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

TROBALT 100 MG Iisrael - inglise - Ministry of Health

trobalt 100 mg

glaxo smith kline (israel) ltd - retigabine 100 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

TROBALT 300 MG Iisrael - inglise - Ministry of Health

trobalt 300 mg

glaxo smith kline (israel) ltd - retigabine 300 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.

TROBALT 400 MG Iisrael - inglise - Ministry of Health

trobalt 400 mg

glaxo smith kline (israel) ltd - retigabine 400 mg - film coated tablets - retigabine - trobalt is indicated as adjunctive treatment of drug-resistant partial onset seizures with or without secondary generalization in patients aged 18 -65 years with epilepsy, where other appropriate drug combinations have proved inadequate or have not been tolerated.